A detailed history of State Of Wyoming transactions in Abb Vie Inc. stock. As of the latest transaction made, State Of Wyoming holds 10 shares of ABBV stock, worth $1,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 936 98.93%
Holding current value
$1,800
Previous $160,000 99.38%
% of portfolio
0.0%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $151,715 - $184,579
-926 Reduced 98.93%
10 $1,000
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $9,596 - $11,207
-62 Reduced 6.21%
936 $160,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $665,011 - $757,718
-4,161 Reduced 80.66%
998 $181,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $37,564 - $42,306
273 Added 5.59%
5,159 $799,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $223,362 - $258,574
1,672 Added 52.02%
4,886 $728,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $11,395 - $14,181
-86 Reduced 2.61%
3,214 $433,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $6,073 - $6,994
-42 Reduced 1.26%
3,300 $525,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $352,275 - $422,470
-2,547 Reduced 43.25%
3,342 $540,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $452,958 - $519,513
3,375 Added 134.25%
5,889 $790,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $345,976 - $439,849
2,514 New
2,514 $385,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $241,259 - $299,335
-1,828 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $130,205 - $164,747
1,212 Added 196.75%
1,828 $248,000
Q3 2021

Feb 14, 2022

BUY
$106.4 - $120.78 $65,542 - $74,400
616 New
616 $66,000
Q2 2021

Feb 11, 2022

SELL
$105.21 - $117.21 $178,436 - $198,788
-1,696 Closed
0 $0
Q1 2021

Feb 08, 2022

BUY
$102.3 - $112.62 $173,500 - $191,003
1,696 New
1,696 $184,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.